Membrane translocation and activation of GnRH receptor sensitize prostate cancer cells to radiation-Reference-Cited by-同舟云学术

Membrane translocation and activation of GnRH receptor sensitize prostate cancer cells to radiation

Published:2021-09-27 Issue:11 Volume:97 Page:1555-1562
ISSN:0955-3002
Container-title:International Journal of Radiation Biology
language:en
Short-container-title:International Journal of Radiation Biology

Author:

Sánchez Catherine¹^ORCID,Mercado Alejandro¹²^ORCID,Contreras Héctor R.²^ORCID,Carvajal V Felipe²^ORCID,Salgado Apolo³,Huidobro Christian¹,Castellón Enrique A.²^ORCID

Affiliation:

1. Clínica Las Condes, Santiago, Chile

2. Departamento de Oncología Básica y Clínica, Facultad de Medicina, Universidad de Chile, Santiago, Chile

3. Instituto Nacional del Cáncer, Santiago, Chile

Funder

Fondecyt

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09553002.2021.1980628

Reference33 articles.

1. High-risk prostate cancer

2. NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016

3. Secretion of prostatic specific antigen, proliferative activity and androgen response in epithelial-stromal co-cultures from human prostate carcinoma

4. Effect of Leuprolide and Cetrorelix on Cell Growth, Apoptosis, and GnRH Receptor Expression in Primary Cell Cultures from Human Prostate Carcinoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uncovering the Secrets of Prostate Cancer’s Radiotherapy Resistance: Advances in Mechanism Research;Biomedicines;2023-06-03

2. Integrated analysis of single-cell and bulk RNA sequencing identifies a signature based on macrophage marker genes involved in prostate cancer prognosis and treatment responsiveness;Functional & Integrative Genomics;2023-04-03

3. Integrated analysis of single‑cell and bulk RNA‑sequencing identifies a signature based on macrophage marker genes involved in prostate cancer prognosis and treatment responsiveness;2022-10-05